Supplementary Materials

This PDF file includes:

  • Table S1. Raw data and SAS code for the data and analyses shown in Table 1.
  • Table S2. Participants’ stable concomitant medications during the 4-week AVP treatment trial.
  • Table S3. Raw data and SAS code testing whether parents could ascertain treatment condition.
  • Table S4. Raw data and SAS code testing whether bottle weights differed between treatment conditions.
  • Table S5. Raw data and SAS code for Fig. 2A and associated analyses.
  • Table S6. Raw data and SAS code testing treatment effects for the SRS-2 using an unweighted analysis.
  • Table S7. Raw data and SAS code testing treatment effects for the SCI subscale of the SRS-2.
  • Table S8. Raw data and SAS code correlating parent SRS-2 ratings with clinician CGI evaluations.
  • Table S9. Raw data and SAS code for Fig. 2B and associated analyses.
  • Table S10. Raw data and SAS code for Fig. 2C and associated analyses.
  • Table S11. Raw data and SAS code for Fig. 2D and associated analyses.
  • Table S12. Raw data and SAS code for Fig. 2E and associated analyses.
  • Table S13. Raw data and SAS code for Fig. 2F and associated analyses.
  • Table S14. Raw data and SAS code testing treatment effects for the RRB subscale of the SRS-2.
  • Table S15. Change from baseline in the safety assessments for the 4-week AVP treatment trial.
  • Table S16. Raw data and SAS code for the data and analyses shown in table S15.

[Download PDF]